Research and Innovation

The University of Newcastle congratulates the Hunter Medical Research Institute (HMRI) as it celebrates its 20th anniversary today, marking two decades of research breakthroughs and extensive community engagement.

University of Newcastle Laureate Professor Kevin Galvin has been awarded the prestigious Antoine M. Gaudin Award, which recognises scientific or engineering contributions that further understanding of the technology of mineral processing.

Two world-leading chemical engineers from the University of Newcastle will chair a major international conference in Newcastle next week, which will focus on the future of accelerated carbonation.

The University of Newcastle has today launched its inaugural Doctoral Training Centre (DTC) focused on supporting the Mining Equipment, Technology and Services (METS) sector.

Three pioneering teams from the University of Newcastle (UON) have been accepted into CSIRO’s ON Prime 4 pre-accelerator program

A ground-breaking development in virtual reality technology at UON has given world-first visual insight into the internal stages of childbearing and its effect on the human body, signifying a huge step for health practitioners and expectant parents globally

Donations from Hunter Community members will support University researchers

Fifteen University of Newcastle subjects have earned a prestigious place among the world’s top 200, including six in the top …

Emerging postdoctoral researcher, Dr Lee Ashton, has been selected to attend the highly prestigious Lindau Nobel Laureate Meeting being held in Germany this June.

Two researchers from the University of Newcastle (UON) have received prestigious international scholarships through the Fulbright Program to further their research in the field of health.

A collaboration between academics and government representatives, the Australia Awards fellowship is aimed at strengthening public service performance and building governance capacity in Kenya.

Oncolytic virotherapy firm Viralytics, which originated from the work of UON's Associate Professor Darren Shafren, has been acquired for $502 million by world-leading pharmaceutical company, Merck.